ARES CAPITAL CORP - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on corporate governance events occurring on May 22, 2017. Ares Capital Corporation held both its Annual Meeting of Stockholders and a Special Meeting of Stockholders in Los Angeles, California. The voting record date was March 9, 2017, with 425,940,681 shares of common stock outstanding entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on shareholder voting results.
Material Changes and Voting Results
Significant corporate actions were approved by shareholders during the meetings:
- Director Elections (Annual Meeting): Three Class I directors were elected to serve three-year terms.
- Michael J. Arougheti: 221,913,380 votes FOR.
- Ann Torre Bates: 224,550,852 votes FOR.
- Steve McKeever: 219,835,057 votes FOR.
- Auditor Ratification (Annual Meeting): The selection of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2017, was approved with 364,208,250 votes FOR.
- Below-NAV Issuance Authorization (Special Meeting): Shareholders approved a proposal authorizing the Company to issue common stock at a price below its then-current net asset value per share. This authorization is subject to limitations, including a cap that the number of shares issued does not exceed 25% of then-outstanding common stock. The proposal received 194,471,524 votes FOR.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the voting outcomes.
Key Facts for Investor Verification
- Verify the specific limitations and conditions attached to the newly authorized below-NAV share issuance.
- Confirm the effective date and duration of the KPMG LLP engagement.
- Review the Company's subsequent 10-Q or 10-K filings for the financial impact of any shares issued under the new authorization.